178 related articles for article (PubMed ID: 26124181)
21. Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.
Kneitz B; Krebs M; Kalogirou C; Schubert M; Joniau S; van Poppel H; Lerut E; Kneitz S; Scholz CJ; Ströbel P; Gessler M; Riedmiller H; Spahn M
Cancer Res; 2014 May; 74(9):2591-603. PubMed ID: 24607843
[TBL] [Abstract][Full Text] [Related]
22. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
[TBL] [Abstract][Full Text] [Related]
23. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
24. IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer.
Dong B; Shi Z; Wang J; Wu J; Yang Z; Fang K
PLoS One; 2015; 10(8):e0134366. PubMed ID: 26252635
[TBL] [Abstract][Full Text] [Related]
25. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
26. microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.
Han G; Fan M; Zhang X
Biochem Biophys Res Commun; 2015 Jan; 456(3):804-9. PubMed ID: 25511701
[TBL] [Abstract][Full Text] [Related]
27. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
Goto Y; Nishikawa R; Kojima S; Chiyomaru T; Enokida H; Inoguchi S; Kinoshita T; Fuse M; Sakamoto S; Nakagawa M; Naya Y; Ichikawa T; Seki N
FEBS Lett; 2014 May; 588(10):1973-82. PubMed ID: 24768995
[TBL] [Abstract][Full Text] [Related]
28. MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer.
Zhang F; Yang Z; Cao M; Xu Y; Li J; Chen X; Gao Z; Xin J; Zhou S; Zhou Z; Yang Y; Sheng W; Zeng Y
Cancer Lett; 2014 Jan; 342(1):121-9. PubMed ID: 24001611
[TBL] [Abstract][Full Text] [Related]
29. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
[TBL] [Abstract][Full Text] [Related]
30. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer.
Xie C; Jiang XH; Zhang JT; Sun TT; Dong JD; Sanders AJ; Diao RY; Wang Y; Fok KL; Tsang LL; Yu MK; Zhang XH; Chung YW; Ye L; Zhao MY; Guo JH; Xiao ZJ; Lan HY; Ng CF; Lau KM; Cai ZM; Jiang WG; Chan HC
Oncogene; 2013 May; 32(18):2282-91, 2291.e1-7. PubMed ID: 22797075
[TBL] [Abstract][Full Text] [Related]
31. Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma.
Dankert JT; Wiesehöfer M; Wach S; Czyrnik ED; Wennemuth G
Sci Rep; 2020 Oct; 10(1):18022. PubMed ID: 33093529
[TBL] [Abstract][Full Text] [Related]
32. Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis.
Kim E; Kim D; Lee JS; Yoe J; Park J; Kim CJ; Jeong D; Kim S; Lee Y
Hepatology; 2018 Jun; 67(6):2287-2301. PubMed ID: 29251790
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b~25.
Liang H; Studach L; Hullinger RL; Xie J; Andrisani OM
Exp Cell Res; 2014 Jan; 320(2):188-99. PubMed ID: 24135225
[TBL] [Abstract][Full Text] [Related]
34. Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.
Khan AP; Poisson LM; Bhat VB; Fermin D; Zhao R; Kalyana-Sundaram S; Michailidis G; Nesvizhskii AI; Omenn GS; Chinnaiyan AM; Sreekumar A
Mol Cell Proteomics; 2010 Feb; 9(2):298-312. PubMed ID: 19955085
[TBL] [Abstract][Full Text] [Related]
35. miR-106b exerts tumor suppressive functions in ovarian carcinoma by directly targeting ZBTB7A.
Yue R; Chen Y; Lai W; Wei W
Minerva Med; 2021 Oct; 112(5):657-658. PubMed ID: 32166935
[No Abstract] [Full Text] [Related]
36. The anti-proliferative effects of enterolactone in prostate cancer cells: evidence for the role of DNA licencing genes, mi-R106b cluster expression, and PTEN dosage.
McCann MJ; Rowland IR; Roy NC
Nutrients; 2014 Nov; 6(11):4839-55. PubMed ID: 25372501
[TBL] [Abstract][Full Text] [Related]
37. Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors.
Ahmad ST; Rogers AD; Chen MJ; Dixit R; Adnani L; Frankiw LS; Lawn SO; Blough MD; Alshehri M; Wu W; Marra MA; Robbins SM; Cairncross JG; Schuurmans C; Chan JA
Nat Commun; 2019 May; 10(1):2000. PubMed ID: 31043608
[TBL] [Abstract][Full Text] [Related]
38. The
Gupta N; Song H; Wu W; Ponce RK; Lin YK; Kim JW; Small EJ; Feng FY; Huang FW; Okimoto RA
Elife; 2022 Nov; 11():. PubMed ID: 36383412
[TBL] [Abstract][Full Text] [Related]
39. Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer.
Kim JW; Luck C; Wu W; Ponce RK; Lin YK; Gupta N; Okimoto RA
Cell Rep; 2022 Oct; 41(1):111443. PubMed ID: 36198276
[TBL] [Abstract][Full Text] [Related]
40. Impact of Capicua on Pancreatic Cancer Progression.
Yoshiya S; Itoh S; Yoshizumi T; Yugawa K; Kurihara T; Toshima T; Harada N; Hashisako M; Yonemasu H; Fukuzawa K; Oda Y; Mori M
Ann Surg Oncol; 2021 Jun; 28(6):3198-3207. PubMed ID: 33216264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]